Health Care – Biden set to mark drug pricing milestone
Congratulations are in order to one Pennsylvania woman who just recently welcomed her 100th great-grandchild. Just imagine that family reunion. In health news, President Biden is […]
drug prices
AARP ad urges Manchin to support Medicare drug negotiation in reconciliation bill
The AARP is launching a multi-million dollar ad campaign across print, radio, cable and TV broadcast networks in West Virginia urging Sen. Joe Manchin (D-W.Va.) […]
November will bring political change. Will it also change drug prices and PDUFA?
Drug prices are on the minds of patients and politicians. The November election is expected to tip the balance of power in Congress and a […]
How celebrity investor Mark Cuban is tackling out-of-control drug prices
American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation […]
Orphan drugs’ financial success raises questions
R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. However, Ben […]
Industry middlemen driving up prices of generic drug prescriptions as much as 20 percent: research
U.S. consumers are overpaying billions for generic drugs due to the cost being driven up by middlemen in the pharmaceutical industry, according to a report […]
Medicare premium increase from Alzheimer’s drug to be lowered next year
Health and Human Services Secretary Xavier Becerra announced on Friday that Medicare premiums would be adjusted for 2023 following a report that found the cost […]
Pharma bad boy Martin Shkreli is on the streets again
Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving AIDS drug around 5,000%, has been released early from his […]
Former OptumRx CEO launches startup Waltz Health with $35M, promising to lower drug costs
Pharmacy benefit managers have been widely criticized for opaque drug pricing practices. But Waltz Health, which was co-founded by former PBM executive Mark Thierer, aims […]
Community welcomes President Biden’s call to action to rein in high drug prices
Now is the time for Congress to answer President Biden’s call to action and pass meaningful drug pricing reform that addresses the artificially inflated cost […]
Nonprofit drugmaker Civica Rx unveils plans for insulin biosimilars, $30 per vial
Civica Rx plans to make lower cost versions of three branded insulin products, biosimilars that are expected to reach the market in 2024. In addition […]
Judge shuts down Servier’s argument that NHS should have stopped prescribing its drugs
A London high court judge ruled this week that the damages paid to the NHS for an anticompetitive action by French pharma company Servier will […]
Shkreli’s former company pays $40m in price-gouging settlement
A pharma company formerly led by ‘pharma bro’ Martin Shkreli has settled a long-running lawsuit with the US federal government over massive price increases for […]
Who won from rising insulin drug prices?
Perhaps surprisingly, the answer is PBMs, not drug manufacturers. That is one of the conclusions discussed in a recent commentary by Good and Hernandez (2021). […]
Medicare drug price negotiation gets new life under Democrat-brokered deal
Not all drugs will be subject to price negotiation under the revised legislation. But the agreement sets up a framework enabling Medicare to negotiate the […]
EQRx Goes Public
Early last year (in those retrospectively blissful pre-pandemic days) I wrote about a startup called EQRx, whose stated mission is to provide lower-cost alternatives to […]
Biden’s latest executive order aims to boost healthcare competition
President Joe Biden has signed a new executive order to tackle anti-competitive behavior across American industries. With regard to healthcare, Biden is directing federal agencies […]
Community Health Plans Are Serious: Support Major Federal Action to Reduce Rx Drug Costs
By CECI CONNOLLY Equal treatment under the law. A foundational pillar of American life. Except when it comes to drug makers who benefit from favorable […]
3 changes coming to drug pricing
No matter if Democrats or Republicans are running the show in Washington, here are three solid bets for pharma companies to plan for in the […]
Oprah’s Meghan & Harry interview reveals global surprise at U.S. pharma ads
Like much U.S. primetime television, the broadcast of Oprah’s interview of Meghan Markle and Prince Harry carried a lot of pharma advertising. The sheer volume […]
Amgen’s Enbrel heads ICER list of unjustified US price rises
US cost effectiveness watchdog ICER found 10 examples of substantial price rises for top-selling medicines in 2019, and concluded that seven of those were not […]
Policy makers should ‘set their sights higher’ on U.S. drug pricing regulations, researchers say
A review published in JAMA found that bills introduced into the House and Senate don’t go nearly as far as existing drug pricing regulations other […]
